8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Nov 7, 2022 · 3y ago · Accession 0000950170-22-022671
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Nov 7, 2022
- Report date
- Nov 5, 2022
- Document
- ntla-20221105.htm
- Size
- 275 KB